Amyloid and tau pathology of familial Alzheimer’s disease APP/PS1 mouse model in a senescence phenotype background (SAMP8)

[1]  D. Butterfield,et al.  Abeta, oxidative stress in Alzheimer disease: evidence based on proteomics studies. , 2014, Biochimica et Biophysica Acta.

[2]  G. Perry,et al.  Phosphorylation of tau protein at sites Ser396–404 is one of the earliest events in Alzheimer's disease and Down syndrome , 2014, Neuropathology and applied neurobiology.

[3]  P. Maher,et al.  Modulation of p25 and inflammatory pathways by fisetin maintains cognitive function in Alzheimer’s disease transgenic mice , 2013, Aging cell.

[4]  Xiang Gao,et al.  Characterization of the APP/PS1 mouse model of Alzheimer's disease in senescence accelerated background , 2013, Neuroscience Letters.

[5]  N. He,et al.  Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease , 2013, Journal of the Neurological Sciences.

[6]  M. Wolfe Toward the structure of presenilin/γ-secretase and presenilin homologs. , 2013, Biochimica et biophysica acta.

[7]  Yueming Li,et al.  Modeling Alzheimer’s Disease in Mouse without Mutant Protein Overexpression: Cooperative and Independent Effects of Aβ and Tau , 2013, PloS one.

[8]  R. Hortigüela,et al.  Aβ increases neural stem cell activity in senescence-accelerated SAMP8 mice , 2013, Neurobiology of Aging.

[9]  S. DeKosky,et al.  Toward the treatment and prevention of Alzheimer's disease: rational strategies and recent progress. , 2013, Annual review of medicine.

[10]  I. Ferrer,et al.  Amyloid Generation and Dysfunctional Immunoproteasome Activation with Disease Progression in Animal Model of Familial Alzheimer's Disease , 2012, Brain pathology.

[11]  Xiaochuan Wang,et al.  Antioxidant Therapies for Alzheimer's Disease , 2012, Oxidative medicine and cellular longevity.

[12]  G. Ricevuti,et al.  Mitochondrial Alterations, Oxidative Stress and Neuroinflammation in Alzheimer's Disease , 2012, International journal of immunopathology and pharmacology.

[13]  J. Morley,et al.  The SAMP8 mouse: a model to develop therapeutic interventions for Alzheimer's disease. , 2012, Current pharmaceutical design.

[14]  M. Antunes,et al.  The novel object recognition memory: neurobiology, test procedure, and its modifications , 2011, Cognitive Processing.

[15]  J. del Valle,et al.  Cerebral Amyloid Angiopathy, Blood-Brain Barrier Disruption and Amyloid Accumulation in SAMP8 Mice , 2011, Neurodegenerative Diseases.

[16]  Xulun Zhang,et al.  Activation and intrinsic γ-secretase activity of presenilin 1 , 2010, Proceedings of the National Academy of Sciences.

[17]  B. S. Manjunath,et al.  Silencing of CDK5 Reduces Neurofibrillary Tangles in Transgenic Alzheimer's Mice , 2010, The Journal of Neuroscience.

[18]  C. Haass,et al.  Three-Amino Acid Spacing of Presenilin Endoproteolysis Suggests a General Stepwise Cleavage of γ-Secretase-Mediated Intramembrane Proteolysis , 2010, The Journal of Neuroscience.

[19]  S. Pimplikar,et al.  Reassessing the amyloid cascade hypothesis of Alzheimer's disease. , 2009, The international journal of biochemistry & cell biology.

[20]  W. Banks,et al.  Increase in Presenilin 1 (PS1) levels in senescence-accelerated mice (SAMP8) may indirectly impair memory by affecting amyloid precursor protein (APP) processing , 2009, Journal of Experimental Biology.

[21]  T. Takeda Senescence-Accelerated Mouse (SAM) with Special References to Neurodegeneration Models, SAMP8 and SAMP10 Mice , 2009, Neurochemical Research.

[22]  P. Wong,et al.  Glu332 in the Nicastrin Ectodomain Is Essential for γ-Secretase Complex Maturation but Not for Its Activity* , 2008, Journal of Biological Chemistry.

[23]  M. Kritzer,et al.  Effects of gonadectomy and hormone replacement on a spontaneous novel object recognition task in adult male rats , 2008, Hormones and Behavior.

[24]  George Perry,et al.  Alzheimer disease, the two-hit hypothesis: an update. , 2007, Biochimica et biophysica acta.

[25]  I. Grundke‐Iqbal,et al.  Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention , 2007, Journal of cellular and molecular medicine.

[26]  Bengt Winblad,et al.  Of mice and men: more neurobiology in dementia , 2006, Current opinion in psychiatry.

[27]  M. Pallàs,et al.  Hyperphosphorylation of microtubule-associated protein tau in senescence-accelerated mouse (SAM) , 2005, Mechanisms of Ageing and Development.

[28]  D. Butterfield,et al.  The senescence-accelerated prone mouse (SAMP8): A model of age-related cognitive decline with relevance to alterations of the gene expression and protein abnormalities in Alzheimer's disease , 2005, Experimental Gerontology.

[29]  Clay W Scott,et al.  Mechanism of γ-secretase cleavage activation: Is γ-secretase regulated through autoinhibition involving the presenilin-1 exon 9 loop? , 2004 .

[30]  Xiongwei Zhu,et al.  Alzheimer's disease: the two-hit hypothesis , 2004, The Lancet Neurology.

[31]  M N Rossor,et al.  The prevalence and causes of dementia in people under the age of 65 years , 2003, Journal of neurology, neurosurgery, and psychiatry.

[32]  A. Agarwal,et al.  Role of reactive oxygen species in the pathophysiology of human reproduction. , 2003, Fertility and sterility.

[33]  J. Morley,et al.  Antibody to Amyloid β Protein Alleviates Impaired Acquisition, Retention, and Memory Processing in SAMP8 Mice , 2002, Neurobiology of Learning and Memory.

[34]  P. Pietrini,et al.  Altered brain functional connectivity and impaired short-term memory in Alzheimer's disease. , 2001, Brain : a journal of neurology.

[35]  René Hen,et al.  Decreased nuclear β‐catenin, tau hyperphosphorylation and neurodegeneration in GSK‐3β conditional transgenic mice , 2001 .

[36]  J. Morley,et al.  β-Amyloid precursor polypeptide in SAMP8 mice affects learning and memory , 2000, Peptides.

[37]  I. Tesseur,et al.  Modeling Alzheimer's disease in transgenic mice: effect of age and of Presenilin1 on amyloid biochemistry and pathology in APP/London mice , 2000, Experimental Gerontology.

[38]  Min Xu,et al.  Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1 , 2000, Nature.

[39]  G. Perry,et al.  How important is oxidative damage? Lessons from Alzheimer's disease. , 2000, Free radical biology & medicine.

[40]  B. Dubois,et al.  Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. , 1999, American journal of human genetics.

[41]  D. Dickson,et al.  Amyloid Phenotype Characterization of Transgenic Mice Overexpressing both Mutant Amyloid Precursor Protein and Mutant Presenilin 1 Transgenes , 1999, Neurobiology of Disease.

[42]  D. Ingram,et al.  Behavioral Assessment of the Senescence-accelerated Mouse (SAM P8 and R1) , 1998, Physiology & Behavior.

[43]  M. Enserink First Alzheimer's Diagnosis Confirmed , 1998, Science.

[44]  J. Morley,et al.  Learning and memory in the SAMP8 mouse , 1997, Neuroscience & Biobehavioral Reviews.

[45]  L. Bahrick,et al.  The effect of retrieval cues on visual preferences and memory in infancy: evidence for a four-phase attention function. , 1997, Journal of experimental child psychology.

[46]  B. Hyman,et al.  Aβ Deposition Is Associated with Neuropil Changes, but not with Overt Neuronal Loss in the Human Amyloid Precursor Protein V717F (PDAPP) Transgenic Mouse , 1997, The Journal of Neuroscience.

[47]  Allan I. Levey,et al.  Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo , 1996, Neuron.

[48]  M. Beal,et al.  Oxidative damage in Alzheimer's , 1996, Nature.

[49]  D. Borchelt,et al.  Endoproteolysis of Presenilin 1 and Accumulation of Processed Derivatives In Vivo , 1996, Neuron.

[50]  J. Wegiel,et al.  Review: David Oppenheimer Memorial Lecture 1995: Some neuropathological aspects of Alzheimer's disease and its relevance to other disciplines * , 1996, Neuropathology and applied neurobiology.

[51]  H. Braak,et al.  Staging of alzheimer's disease-related neurofibrillary changes , 1995, Neurobiology of Aging.

[52]  L. Mucke,et al.  Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein , 1995, Nature.

[53]  R. Itzhaki Possible factors in the etiology of Alzheimer's disease , 1994, Molecular Neurobiology.

[54]  A. Nagaoka,et al.  Senescence-accelerated mouse (SAM): Age-related reduced anxiety-like behavior in the SAM-P/8 strain , 1992, Physiology & Behavior.

[55]  K. Jellinger,et al.  Accumulation of abnormally phosphorylated τ precedes the formation of neurofibrillary tangles in Alzheimer's disease , 1989, Brain Research.

[56]  Ichiro Akiguchi,et al.  Age-related deterioration of ability of acquisition in memory and learning in senescence accelerated mouse: SAM-P/8 as an animal model of disturbances in recent memory , 1988, Brain Research.

[57]  A. Nagaoka,et al.  Age-related changes in learning and memory in the senescence-accelerated mouse (SAM) , 1986, Physiology & Behavior.

[58]  G. Glenner,et al.  Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. , 1984, Biochemical and biophysical research communications.

[59]  Keiichi Higuchi,et al.  A new murine model of accelerated senescence , 1981, Mechanisms of Ageing and Development.

[60]  Hyoung-Gon Lee,et al.  Neuronal cell cycle re-entry markers are altered in the senescence accelerated mouse P8 (SAMP8). , 2012, Journal of Alzheimer's disease : JAD.

[61]  J. del Valle,et al.  Characterization of amyloid-β granules in the hippocampus of SAMP8 mice. , 2011, Journal of Alzheimer's Disease.

[62]  G. Casadesus,et al.  Early amyloid accumulation in the hippocampus of SAMP8 mice. , 2010, Journal of Alzheimer's disease : JAD.

[63]  Wiesje M van der Flier,et al.  Early-versus late-onset Alzheimer's disease: more than age alone. , 2010, Journal of Alzheimer's disease : JAD.

[64]  G. Perry,et al.  From aging to Alzheimer's disease: unveiling "the switch" with the senescence-accelerated mouse model (SAMP8). , 2008, Journal of Alzheimer's disease : JAD.

[65]  Manuel Buttini,et al.  Mice as models: transgenic approaches and Alzheimer's disease. , 2006, Journal of Alzheimer's disease : JAD.

[66]  Apoorva Mandavilli,et al.  Of mice and men , 2006, Nature Medicine.

[67]  Clay W Scott,et al.  Mechanism of gamma-secretase cleavage activation: is gamma-secretase regulated through autoinhibition involving the presenilin-1 exon 9 loop? , 2004, Biochemistry.

[68]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[69]  X. Gironés,et al.  Actualización sobre la patología de la enfermedad de Alzheimer , 2002 .

[70]  R. Hen,et al.  Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. , 2001, The EMBO journal.

[71]  N. Tumosa,et al.  Beta-amyloid precursor polypeptide in SAMP8 mice affects learning and memory. , 2000, Peptides.

[72]  A. Nadin,et al.  Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1. , 2000, Nature.

[73]  M. Hosokawa,et al.  Senescence-accelerated mouse. , 1999, Methods in enzymology.

[74]  H. Braak,et al.  Evolution of neuronal changes in the course of Alzheimer's disease. , 1998, Journal of neural transmission. Supplementum.